양덕환 (전남대학교 의과대학, 화순전남대학교병원)님 | 한빛사연구자 > 한빛사

전남대학교 의과대학, 화순전남대학교병원

최종업데이트 2020.12.29.

Prognostic Value of 18F-FDG PET in Primary Central Nervous System Lymphoma: Assessing Interim Metabolic Response for Improving Patient Stratification
- Clin. Nucl. Med., Feb 17 2025, | https://doi.org/10.1097/RLU.0000000000005703
- 2025-02
- 의약학
- 한빛사논문
CD8+ TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigens
- J. Immunother. Cancer, Online issue publication September 30, 2021 | doi: 10.1136/jitc-2021-002709
- 2021-09
- 의약학
- 한빛사논문
Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): An open-label phase 1/2 trial
- Ann. Oncol., Available online 25 December 2020 | https://doi.org/10.1016/j.annonc.2020.12.009
- 2020-12
- 의약학
- 한빛사논문

연구자 ID

저자논문